Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin D Foust

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Systemic Gene Therapy for Targeting the CNSSara E Gombash, Kevin D Foust
Cell Cycle (Georgetown, Tex.)|December 2, 2009
Over the barrier and through the blood: to CNS delivery we goKevin D Foust, Brian K Kaspar
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
Recombinant AAV delivery to the central nervous systemOlivier Bockstael, Kevin D Foust, Brian Kaspar, et al.
Journal of Visualized Experiments : Jove|November 20, 2014
Intravenous injections in neonatal miceSara E Gombash Lampe, Brian K Kaspar, Kevin D Foust
Current Gene Therapy|October 29, 2009
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALSMark E Hester, Kevin D Foust, Rita W Kaspar, et al.
Human Gene Therapy|December 13, 2007
Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the ratKevin D Foust, Terence R Flotte, Paul J Reier, et al.
Human Gene Therapy|December 7, 2007
Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neuronsKevin D Foust, Amy Poirier, Christina A Pacak, et al.
Neuron|July 17, 2015
Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS MiceYuxiang Xie, Bing Zhou, Mei-Yao Lin, et al.
Nature Biotechnology|December 23, 2008
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesKevin D Foust, Emily Nurre, Chrystal L Montgomery, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2006
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disordersRonald J Mandel, Fredric P Manfredsson, Kevin D Foust, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2015
Systemic Gene Therapy for Targeting the CNSSara E Gombash, Kevin D Foust
Cell Cycle (Georgetown, Tex.)|December 2, 2009
Over the barrier and through the blood: to CNS delivery we goKevin D Foust, Brian K Kaspar
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
Recombinant AAV delivery to the central nervous systemOlivier Bockstael, Kevin D Foust, Brian Kaspar, et al.
Journal of Visualized Experiments : Jove|November 20, 2014
Intravenous injections in neonatal miceSara E Gombash Lampe, Brian K Kaspar, Kevin D Foust
Current Gene Therapy|October 29, 2009
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALSMark E Hester, Kevin D Foust, Rita W Kaspar, et al.
Human Gene Therapy|December 13, 2007
Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the ratKevin D Foust, Terence R Flotte, Paul J Reier, et al.
Human Gene Therapy|December 7, 2007
Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neuronsKevin D Foust, Amy Poirier, Christina A Pacak, et al.
Neuron|July 17, 2015
Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS MiceYuxiang Xie, Bing Zhou, Mei-Yao Lin, et al.
Nature Biotechnology|December 23, 2008
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesKevin D Foust, Emily Nurre, Chrystal L Montgomery, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2006
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disordersRonald J Mandel, Fredric P Manfredsson, Kevin D Foust, et al.
Pageof 4